Patients with metabolic syndrome exhibit higher platelet activity than those with conventional risk factors for vascular disease
- PMID: 17530178
- DOI: 10.1007/s11239-007-0047-3
Patients with metabolic syndrome exhibit higher platelet activity than those with conventional risk factors for vascular disease
Abstract
Background: The metabolic syndrome is a matter of ongoing debate with regard to its existence, classification, clinical meaningfulness, and associated risks for vessel occlusion. Considering that persistent platelet activation is a cornerstone for the development of acute vascular events, and that patients with type 2 diabetes consistently exhibit high platelet activity, these characteristics may be critical for distinguishing and triageing specific features of metabolic syndrome among established risk factors for vascular disease.
Methods: We assessed the platelet activity by conventional aggregation, expression of major surface receptors by flow cytometry, and quantitatively by rapid bedside analyzers in 20 aspirin-naïve patients with documented metabolic syndrome, and compared these with 20 untreated subjects with multiple cardiovascular risk factors.
Results: Closure time by the PFA-100 analyzer was significantly (P = 0.002) shorter in patients with metabolic syndrome indicating platelet inhibition under high shear conditions. Ultegra analyzer readings revealed increased fibrinogen binding (P = 0.0003) what in combination with the increased expression of PAC-1 (P = 0.32) strongly suggest activation of platelet glycoprotein IIb/IIIa receptor. Surface expression of CD107a (P = 0.014), and SPAN-12 (P = 0.003) were also higher in patients with metabolic syndrome. In contrast, platelet aggregation induced by collagen or ADP, CD31, CD41, CD42b, CD51/61, CD62p, CD63, CD154, CD165, so as formation of platelet-monocyte aggregates, PAR-1 thrombin receptor, and thrombospondin did not differ between groups.
Conclusion: Patients with metabolic syndrome exhibited a higher degree of platelet activation than subjects with conventional risk factors for vascular disease. Conceptually, applying adequate antiplatelet strategies may reduce the risk of acute thrombotic events in these patients. Further prospective studies exploring this notion are encouraged.
Similar articles
-
Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.Thromb Res. 2004;113(3-4):197-204. doi: 10.1016/j.thromres.2004.03.002. Thromb Res. 2004. PMID: 15140583
-
Antiplatelet properties of escitalopram in patients with the metabolic syndrome: a dose-ranging in vitro study.Neuropsychopharmacology. 2007 Nov;32(11):2369-74. doi: 10.1038/sj.npp.1301355. Epub 2007 Mar 14. Neuropsychopharmacology. 2007. PMID: 17356575
-
Early impact of prescription Omega-3 fatty acids on platelet biomarkers in patients with coronary artery disease and hypertriglyceridemia.Cardiology. 2011;118(3):187-94. doi: 10.1159/000329300. Epub 2011 Jun 22. Cardiology. 2011. PMID: 21701167 Clinical Trial.
-
The in vitro effects of niacin on platelet biomarkers in human volunteers.Thromb Haemost. 2010 Aug;104(2):311-7. doi: 10.1160/TH10-01-0015. Epub 2010 Jun 10. Thromb Haemost. 2010. PMID: 20539903
-
Platelet hyperreactivity: predictive and intrinsic properties.Hematol Oncol Clin North Am. 2007 Aug;21(4):633-45, v-vi. doi: 10.1016/j.hoc.2007.06.002. Hematol Oncol Clin North Am. 2007. PMID: 17666282 Free PMC article. Review.
Cited by
-
High prevalence of aspirin resistance in elderly patients with cardiovascular disease and metabolic syndrome.J Geriatr Cardiol. 2016 Sep;13(6):531-6. doi: 10.11909/j.issn.1671-5411.2016.06.009. J Geriatr Cardiol. 2016. PMID: 27582771 Free PMC article.
-
Modification of platelet proteins by malondialdehyde: prevention by dicarbonyl scavengers.J Lipid Res. 2015 Nov;56(11):2196-205. doi: 10.1194/jlr.P063271. Epub 2015 Sep 16. J Lipid Res. 2015. PMID: 26378094 Free PMC article.
-
Suboptimal inhibition of platelet cyclooxygenase-1 by aspirin in metabolic syndrome.Hypertension. 2012 Mar;59(3):719-25. doi: 10.1161/HYPERTENSIONAHA.111.181404. Epub 2012 Feb 6. Hypertension. 2012. PMID: 22311905 Free PMC article. Clinical Trial.
-
Evaluation of Aspirin and Clopidogrel resistance in patients with Acute Coronary Syndrome by using Adenosine Diposphate Test and Aspirin Test.Pak J Med Sci. 2013 Jan;29(1):97-102. doi: 10.12669/pjms.291.2820. Pak J Med Sci. 2013. PMID: 24353516 Free PMC article.
-
Effects of Oral Sodium Nitrite on Blood Pressure, Insulin Sensitivity, and Intima-Media Arterial Thickening in Adults With Hypertension and Metabolic Syndrome.Hypertension. 2020 Sep;76(3):866-874. doi: 10.1161/HYPERTENSIONAHA.120.14930. Epub 2020 Aug 3. Hypertension. 2020. PMID: 32755471 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous